We anticipate a shortfall of £1.5 million in our funding programme this year to resume current research and support vital new projects. This could have a catastrophic knock-on effect for stroke research and delay access to important new life-changing treatments that allow people to rebuild their lives after stroke.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take-homes from our International Development Officer, Sarah Belson.
As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions.
The Stroke Association's Keynote Lecture is a prestigious event which showcases the latest advancements being made in stroke research.
Find out more about our 2016 Keynote Lecture.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.
Presented at the International Stroke Conference 2016, the final results from the PISTE trial (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) add new evidence for the effectiveness of mechanical clot retri
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
In recent years, legal cannabis-based products containing cannabidiol (CBD), have become more available. Could these help stroke survivors to cope with problematic effects of stroke?
This year’s Winter School was attended by 21 trainees from across 11 countries. They took part in a jam-packed programme delivered by a wide range of experts in the field of stroke research, publication and communication.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.